Search Results - "Feijen, Elizabeth A. M"
-
1
Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity
Published in JAMA oncology (01-06-2019)“…Anthracyclines are part of many effective pediatric cancer treatment protocols. Most pediatric oncology treatment groups assume that the hematologic toxicity…”
Get more information
Journal Article -
2
Acute and early-onset cardiotoxicity in children and adolescents with cancer: a systematic review
Published in BMC cancer (14-09-2023)“…Abstract Background Cardiotoxicity is among the most important adverse effects of childhood cancer treatment. Anthracyclines, mitoxantrone and radiotherapy…”
Get full text
Journal Article -
3
A new method to facilitate valid and consistent grading cardiac events in childhood cancer survivors using medical records
Published in PloS one (09-07-2014)“…Cardiac events (CEs) are among the most serious late effects following childhood cancer treatment. To establish accurate risk estimates for the occurrence of…”
Get full text
Journal Article -
4
Late Cardiac Events after Childhood Cancer: Methodological Aspects of the Pan-European Study PanCareSurFup
Published in PloS one (19-09-2016)“…Childhood cancer survivors are at high risk of long-term adverse effects of cancer and its treatment, including cardiac events. The pan-European PanCareSurFup…”
Get full text
Journal Article -
5
Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic review
Published in Journal of cancer survivorship (01-04-2022)“…Purpose Echocardiographic surveillance for asymptomatic left ventricular systolic dysfunction (ALVSD) is advised in childhood cancer survivors (CCS), because…”
Get full text
Journal Article -
6
The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer
Published in European journal of cancer (1990) (01-11-2018)“…Second malignant neoplasms and cardiotoxicity are among the most serious and frequent adverse health outcomes experienced by childhood and adolescent cancer…”
Get full text
Journal Article -
7
Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis
Published in Journal of molecular medicine (Berlin, Germany) (01-09-2021)“…As in other cardiomyopathies, extracellular matrix (ECM) remodeling plays an important role in anthracycline-induced cardiomyopathy. To understand the pattern…”
Get full text
Journal Article -
8
The Dutch LATER physical outcomes set for self-reported data in survivors of childhood cancer
Published in Journal of cancer survivorship (01-10-2020)“…Purposes Studies investigating self-reported long-term morbidity in childhood cancer survivors (CCS) are using heterogeneous outcome definitions, which…”
Get full text
Journal Article -
9
Electrocardiographic abnormalities in childhood cancer survivors treated with cardiotoxic therapy: a systematic review
Published in Pediatric blood & cancer (01-08-2022)“…Purpose The purpose of this study is to assess the available literature on the prevalence and risk factors of electrocardiographic (ECG) abnormalities after…”
Get full text
Journal Article -
10
Secondary prevention of anthracycline cardiotoxicity in childhood cancer survivors
Published in The lancet oncology (01-02-2024)“…In post-hoc analyses, cardiac-event free survival was found to potentially be superior in the carvedilol group compared with the placebo group in the…”
Get full text
Journal Article -
11
The cancer patient and cardiology
Published in European journal of heart failure (01-12-2020)“…Advances in cancer treatments have improved clinical outcomes, leading to an increasing population of cancer survivors. However, this success is associated…”
Get full text
Journal Article -
12
Individual prediction of heart failure among childhood cancer survivors
Published in Journal of clinical oncology (10-02-2015)“…To create clinically useful models that incorporate readily available demographic and cancer treatment characteristics to predict individual risk of heart…”
Get full text
Journal Article -
13
Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer
Published in Journal of clinical oncology (01-01-2018)“…Purpose We aimed to predict individual risk of ischemic heart disease and stroke in 5-year survivors of childhood cancer. Patients and Methods Participants in…”
Get full text
Journal Article -
14
Childhood cancer and hematological disorders negatively affect spermatogonial quantity at diagnosis: a retrospective study of a male fertility preservation cohort
Published in Human reproduction (Oxford) (01-03-2023)“…Abstract STUDY QUESTION What is the impact of cancer or hematological disorders on germ cells in pediatric male patients? SUMMARY ANSWER Spermatogonial…”
Get full text
Journal Article -
15
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer
Published in Journal of clinical oncology (10-11-2015)“…Cumulative anthracycline dose is one of the strongest predictors of heart failure (HF) after cancer treatment. However, the differential risk for…”
Get full text
Journal Article -
16
Large variation in assessment and outcome definitions to describe the burden of long‐term morbidity in childhood cancer survivors: A systematic review
Published in Pediatric blood & cancer (01-11-2020)“…We systematically reviewed outcome assessment methods, outcome classification, and severity grading of reported outcomes in studies investigating the burden of…”
Get full text
Journal Article -
17
Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines
Published in Cochrane database of systematic reviews (27-09-2022)“…This review is the third update of a previously published Cochrane Review. The original review, looking at all possible cardioprotective agents, was split and…”
Get more information
Journal Article -
18
Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study
Published in Journal of clinical oncology (01-01-2023)“…Heart failure (HF) is a potentially life-threatening complication of treatment for childhood cancer. We evaluated the risk and risk factors for HF in a large…”
Get full text
Journal Article -
19
Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe
Published in JNCI : Journal of the National Cancer Institute (01-06-2018)“…Abstract Background Childhood cancer survivors are at risk of subsequent primary soft-tissue sarcomas (STS), but the risks of specific STS histological…”
Get full text
Journal Article -
20
Comment on: Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane
Published in Pediatric blood & cancer (01-10-2023)Get full text
Journal Article